Cephalon’s Nuvigil For Jet Lag Is Pulled Off The Runway; Bipolar Indication Remains On The Horizon
This article was originally published in The Pink Sheet Daily
Executive Summary
A second “complete response” letter from FDA derails development of the jet lag claim; Cephalon repeatedly has struck out in seeking a new indication to differentiate the wakefulness drug from Provigil.